Fingerprint
Dive into the research topics of 'Long-term safety of intravenous ibandronic acid for up to 4 years in metastatic breast cancer: an open-label trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Martin Pecherstorfer, Saul Rivkin, Jean-Jacques Body, Ingo Diel, Bengt Bergström
Research output: Journal article (peer-reviewed) › Journal article